Figure 1:

Figure 2:
![Area under the curve [analyzed using area under the disease progress curve (AUDPC) statistical analyses] for mealworm mortality following infection with three entomopathogenic nematode species, produced in vivo or in vitro and formulated in Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH), assessed at two weeks intervals over a period of eight weeks. Different letters at each bar indicate significant differences between treatments (α = 0.05), compared for each nematode species separately.](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/67b0d9fe082aa65dea3f1943/j_jofnem-2025-0014_fig_002.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKPKOO2DC7%2F20260120%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260120T115244Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEN%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaDGV1LWNlbnRyYWwtMSJGMEQCIF0WIkRVJ%2FhVKjI5frMILsCjMB%2BDVYnuKZGWmTwd3380AiA69d5BXI3mUZfToabfzypqdmb3Geuyq9mvFHhPiO93GyrEBQio%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F8BEAIaDDk2MzEzNDI4OTk0MCIMYnTi75PiKijDRUDiKpgFJXUqf2SJMuCm%2BYfAsdDRRDFh%2FPLnfa9cdjaoZ6nh9RZCxuxBPNhLQqmR2uWl0uub8p9KTrhrcG5ooDoMEEEofQ7ral2b4tHPvWkkNZckmNevIpTWef7RQ6clEcuSgryxKajB6FEJ6NhCkS1I8iXqnmrs1rnFU9pz%2FGPq9B3T38PYuqkXXejCUlRgNVgBFHM9VhwfaWGkUMcHCsKYO%2F1w5A3v7CGirlckp%2FoXCZ3s8wH%2BoaoRTXIBzmCxcZpWYiEYnvMzSDu%2F4XWVDxEqhZQBzjmjeeYHzDkB30H2LWo3%2Fpa1%2B1YsA6tomhUXz7C3HWqoxUd0rbZQvB%2FAd6RhaNadpPR5j1g51av5WIjDAaLEOXAWwzDMiV8U5D3Y9GhiM8NCiSQg%2BAqC3yYncvLZ5kvgpkbS3MzBhmzKfsHNtwHYDsZIMcrDM0fHlQuFuPG9H2Ck2D3iPd4ATnARWx0q2nzRtHFjBmD4qpkd19chR38F7qdRvc46PTXP5f1E1FHZd8R5tiw3ALqjXNcHmxB1gv5acWz7rkFUT3gq53i9r1LMr%2FeZ813OJyZS9wtc%2B%2F9pZi%2FFNRHXt7byPj%2BCZyf6zDtiGnnNNrR4rq6j0tYSJFQptt8%2BhHm0VZ9b2itfOwQn31LZlwfLnELBDo5fZK%2FWcU2Js4Ny6PLBbqRdrf3PodidHaLQdztBG6CDcQcFude330l5%2Fd9Cn6CUlugf4yv0mHFSUQzT%2FmlqSniA1mM0jcZahoJX86I1gqnOrs%2BGaQZzstr5WZbgoWmkLlkhukca0kx%2F0CatYF9LaT2lAkQwmXj0kcMRWzudg2XUVR0h3yQju0CNfo5zMYFIFgD%2FiYE3A2h6NVZwr2BGQ%2FhyuiGvRQ%2FUGYqQDxbhPMWrVTDX07zLBjqyAeXNQeKtX397eUIq3%2BQ6L4L8%2FNLlLqthLH6jsoB0Pz6iYnjmsMO8ey1XkcKR9AOwGZYW7Ae9etWeMkQvuAAgqsyU5wlMWc40FUeS3reE%2BQ7z%2BOdc0pNSvNaJQBI4ciUTnE0p06jUDKHcSVLTyLx4UkAdzmZht8gvJbV4CmnXVXHwBWARxixVvNBETFPP%2FdGbJGciHI4%2B1Jph4s6gMUGFqjgHKfLJYVFItAYS4YUHYADZ6y4%3D&X-Amz-Signature=d5c1225b9331e8710a961a8feea46c4ae7bde21c9850e5c393c355d3aa48a493&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Survival of entomopathogenic nematodes produced in vivo and in vitro and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P < 0001) = 20_64)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 59 a | 56 a | 37 b | 13 a |
| In vitro B | 100 a | 64 a | 65 a | 67 a | 8 a | |
| In vivo PPH | 100 a | 59 a | 55 a | 37 b | 13 a | |
| In vitro PPH | 100 a | 61 a | 63 a | 68 a | 10 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 76 a | 60 a | 47 b | 4 a |
| In vitro B | 100 a | 62 b | 57 a | 66 a | * | |
| In vivo PPH | 100 a | 76 a | 60 a | 47 b | 4 a | |
| In vitro PPH | 100 a | 62 b | 63 a | 66 c | 2 a | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * | |
| SGI 35 | In vivo B | 100 a | 68 a | 53 a | 47 b | * |
| In vitro B | 100 a | 58 b | 63 a | 68 a | * | |
| In vivo PPH | 100 a | 68 a | 53 a | 47 b | * | |
| In vitro PPH | 100 a | 60 b | 69 a | 69 a | 1 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |
Table showing infectivity of entomopathogenic nematodes produced in vivo and in vitro against Tenebrio molitor and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P = 0,05) = 6,1742)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 90 a | 93 a | 70 a | 57 a |
| In vitro B | 100 a | 83 a | 77 b | 70 a | 50 a | |
| In vivo PPH | 100 a | 90 a | 90 a | 70 a | 53 a | |
| In vitro PPH | 100 a | 90 a | 80 b | 73 a | 53 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 97 a | 100 a | 83 a | 90 a |
| In vitro B | 100 a | 97 a | 73 c | 67 b | * | |
| In vivo PPH | 100 a | 100 a | 100 a | 90 a | 93 a | |
| In vitro PPH | 100 a | 100 a | 80 b | 67 b | 93 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| SGI 35 | In vivo B | 100 a | 93 a | 90 a | 80 a | * |
| In vitro B | 100 a | 80 b | 77 a | 57 b | * | |
| In vivo PPH | 100 a | 93 a | 90 a | 80 a | * | |
| In vitro PPH | 100 a | 80 b | 80 a | 60 b | 93 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |